Roivant Sciences Ltd., 10% Owner at Immunovant, Inc. (IMVT), bought 2,068,966 shares at $14.50 ($30.0M) on 2020-04-16, disclosed to the SEC on 2020-04-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.50 | 1,034,483 | $15.0M | 50.0% |
| 2 | $14.50 | 1,034,483 | $15.0M | 50.0% |
| Total | $14.50 avg | 2,068,966 | $30.0M | 100% |
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |